We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

80 hedge funds and large institutions have $434M invested in La Jolla Pharmaceutical Company in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

50% more call options, than puts

Call options by funds: $996K | Put options by funds: $664K

11% more funds holding

Funds holding: 72 → 80 (+8)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less capital invested

Capital invested by funds: $447M → $434M (-$12.3M)

Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
17
Increased
37
Reduced
22
Closed
9
Calls
$996K
Puts
$664K
Net Calls
+$332K
Net Calls Change
-$1.95M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$7.89M
2
OM
Opaleye Management
Massachusetts
+$3.82M
3
JHIU
Janus Henderson Investors US
Colorado
+$1.98M
4
BC
Broadfin Capital
New York
+$1.91M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.8M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$10.9M
2
Morgan Stanley
Morgan Stanley
New York
-$3.77M
3
EI
EAM Investors
California
-$1.87M
4
DM
Deerfield Management
New York
-$1.81M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$1.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAWC
26
P.A.W. Capital
Connecticut
$1.36M +$65.4K +2,400 +5%
BIM
27
BlackRock Investment Management
Delaware
$1.29M +$7.66K +281 +0.6%
CCA
28
Catalyst Capital Advisors
New York
$1.22M – – –
LCM
29
Landscape Capital Management
New Jersey
$1.2M +$888K +32,563 +274%
TCIM
30
TIAA CREF Investment Management
New York
$1.12M +$59.1K +2,169 +6%
UBS Group
31
UBS Group
Switzerland
$1.02M +$781K +28,637 +310%
BGA
32
Belmont Global Advisors
Texas
$1.01M +$68.8K +2,522 +7%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.01M +$1.02M +37,300 New
Citadel Advisors
34
Citadel Advisors
Florida
$984K -$885K -32,458 -47%
TAM
35
Tocqueville Asset Management
New York
$821K +$624K +22,900 +305%
EI
36
EAM Investors
California
$779K -$1.87M -68,480 -70%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$690K +$12.2K +449 +2%
RFC
38
Russell Frank Company
Washington
$647K +$252K +9,224 +64%
AAM
39
Advisors Asset Management
Colorado
$632K +$265K +9,711 +71%
TA
40
Teachers Advisors
New York
$621K +$168K +6,169 +37%
HCM
41
Hollencrest Capital Management
California
$596K -$625K -22,908 -51%
Charles Schwab
42
Charles Schwab
California
$583K +$136K +5,000 +30%
Swiss National Bank
43
Swiss National Bank
Switzerland
$540K +$545K +20,000 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$415K +$107K +3,915 +34%
BBA
45
Baker Bros. Advisors
New York
$371K -$10.9M -398,262 -97%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$367K +$57.3K +2,100 +18%
AL
47
Airain Ltd
Guernsey
$363K +$367K +13,451 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$358K +$84.9K +3,115 +31%
CS
49
Credit Suisse
Switzerland
$344K -$948K -34,762 -73%
CCM
50
Cadence Capital Management
Massachusetts
$326K +$329K +12,060 New
1
2
3 4

LJPC Hedge Fund Activity: Q4 2015 in Review

80 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q4 2015, worth a combined $434M — down 2.8% from $447M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new LJPC positions and 9 closed out — a net gain of 8 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was State Street, adding an estimated $7.89M. The largest seller was Baker Bros. Advisors, cutting an estimated $10.9M.

  • 80 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q4 2015, up from 72 in Q3 2015.
  • Funds reported $434M of La Jolla Pharmaceutical Company stock for Q4 2015, down 2.8% quarter-over-quarter.
  • 17 funds opened new La Jolla Pharmaceutical Company positions in Q4 2015 and 9 closed out, a net change of +8 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q4 2015 was State Street, an estimated $7.89M added.
  • The largest La Jolla Pharmaceutical Company seller in Q4 2015 was Baker Bros. Advisors, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2015.